Literature DB >> 21950375

Progress against cancer (1971-2011): how far have we come?

A K Tiwari1, H K Roy.   

Abstract

'The big C', a common euphemism for cancer, has loomed large on the collective psyche of the mankind for centuries, not least because of the relative dearth of effective treatment against this disease but its ability to relentlessly evade them and come back to haunt us. However, the struggle against cancer took a decisive turn in 1971 when a relentless campaigning by health activists eventually led to signing of the National Cancer Act in the United States, an unprecedented event in the history of diseases. As we commemorate the 40th anniversary of the signing of that historic legislation, an assessment of the progress against cancer would naturally help us understand how we have fared so far in this struggle and guide us in our efforts to re-strategize and re-deploy our limited resources to their best use against this immortal enemy.
© 2011 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21950375      PMCID: PMC3270124          DOI: 10.1111/j.1365-2796.2011.02462.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  50 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Stat bite: Estimated effect of finasteride on prostate cancer development.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

3.  New treatments for colon cancer.

Authors:  Maurice Slevin; Sarah Payne
Journal:  BMJ       Date:  2004-07-17

4.  DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA.

Authors:  D Stehelin; H E Varmus; J M Bishop; P K Vogt
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

5.  The national cancer act of 1971.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

6.  National Cancer Act of 1971--an editorial.

Authors:  S Weinhouse
Journal:  Cancer Res       Date:  1972-04       Impact factor: 12.701

7.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

8.  Overriding imatinib resistance with a novel ABL kinase inhibitor.

Authors:  Neil P Shah; Chris Tran; Francis Y Lee; Ping Chen; Derek Norris; Charles L Sawyers
Journal:  Science       Date:  2004-07-16       Impact factor: 47.728

Review 9.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  8 in total

1.  Assessing progress in reducing the burden of cancer mortality, 1985-2005.

Authors:  Samir Soneji; Hiram Beltrán-Sánchez; Harold C Sox
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

2.  Development and utilization of complementary communication channels for treatment decision making and survivorship issues among cancer patients: The CIS Research Consortium Experience.

Authors:  Linda Fleisher; Kuang Yi Wen; Suzanne M Miller; Michael Diefenbach; Annette L Stanton; Mary Ropka; Marion Morra; Peter C Raich
Journal:  Internet Interv       Date:  2015-11-01

3.  A History of Health Economics and Healthcare Delivery Research at the National Cancer Institute.

Authors:  V Paul Doria-Rose; Nancy Breen; Martin L Brown; Eric J Feuer; Ann M Geiger; Larry Kessler; Joseph Lipscomb; Joan L Warren; K Robin Yabroff
Journal:  J Natl Cancer Inst Monogr       Date:  2022-07-05

4.  Pegylation of phenothiazine - A synthetic route towards potent anticancer drugs.

Authors:  Sandu Cibotaru; Valentin Nastasa; Andreea-Isabela Sandu; Andra-Cristina Bostanaru; Mihai Mares; Luminita Marin
Journal:  J Adv Res       Date:  2021-07-09       Impact factor: 12.822

5.  Perspectives on communication and engagement with regard to collecting biospecimens and family health histories for cancer research in a rural Alaska Native community.

Authors:  Lisa G Dirks; Jennifer L Shaw; Vanessa Y Hiratsuka; Julie A Beans; Janet J Kelly; Denise A Dillard
Journal:  J Community Genet       Date:  2019-01-30

6.  Hypothermia activates adipose tissue to promote malignant lung cancer progression.

Authors:  Gangjun Du; Bei Zhao; Yaping Zhang; Ting Sun; Weijie Liu; Jiahuan Li; Yinghui Liu; Yingying Wang; Hong Li; Xidong Hou
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 7.  Overcoming tumor immune evasion with an unique arbovirus.

Authors:  Bruce Lyday; Tony Chen; Santosh Kesari; Boris Minev
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

8.  Emerging cancer incidence, mortality, hospitalisation and associated burden among Australian cancer patients, 1982 - 2014: an incidence-based approach in terms of trends, determinants and inequality.

Authors:  Rashidul Alam Mahumud; Khorshed Alam; Jeff Dunn; Jeff Gow
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.